20 Jun CNBC: Exact Sciences’ shares pop on positive Cologuard trial results Posted at 14:58h in Featured, Resident Company News, URP News by Diana Starr Kevin Conroy, Exact Sciences CEO, joins ‘Fast Money’ to discuss Exact Sciences latest trial results for its colo-rectal cancer tests, Cologuard. Watch video at CNBC: Share Print page